Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Japan Jof Stock Losing Momentum Price At 11.01 Up 0.64 20260410 Drmaw Stock Analysis Dermata Therapeutics Inc. Warrant Down 5.88 To 0.02 Near Key Support Levels 20260401 What Is The Volatility Of Nuveen Jrs Stock Price At 7.64 Down 0.13 20260408 Is Yatsen Ysg Stock Discounted Now Price At 3.10 Up 1.64 20260406 Is Niq Global Niq Stock Declining Price At 11.88 Up 3.48 20260406 ASML Holding ASML Detailed Report Q1 2026 Profit Surprises How LivaNova PLC LIVN management quality shows in execution Q1 2026 Profit Surprises Beyond Air XAIR Market Position Q1 2026 Profit Surprises What Bon Natural BON is doing to expand margins BON Q3 Earnings Bon Natural Reports Quarterly Results Is Sachem SACH stock showing defensive strength Q4 2025 Profit Surprises SM SM Energy tops Q3 2000 EPS estimates posts 175 percent annual revenue growth shares rise 37 percent Quanta Services PWR Stock Coverage Dropped Smart Money Flows 20260420 Core Labs CLB Stock Earnings Report Weakens 20260420 Ally ALLY Stock Directional Bias Eye on Rally 20260420 TCRT Alaunos Therapeutics posts wider Q4 2023 loss than analyst estimates with shares slipping 039 percent in todays trading Xcel Energy Inc XEL Q1 2026 Earnings InLine With Consensus Revenue Miss Offset by YoY Growth and Stable FullYear Guidance AEHL Antelope delivers 77 percent EPS beat for Q3 2012 shares fall 123 percent in todays trading CW CurtissWright posts narrow 02 percent Q4 2025 EPS miss pushing shares down nearly 1 percent today Equinix Inc EQIX Secures TopTier Position in FastGrowing Turkish Colocation Market Per 2026 Industry Report AIADMKs Anbalagan Appointed Pro Tem Speaker of Puducherry Assembly Signaling Political Shift HALO Stocks Emerge as Top Theme ETF Now Targets Assets Immune to AI Disruption Bitfarms BITF Q4 2025 Earnings Miss by Significant Key Takeaways RLX RLX Q4 2025 Earnings Surprise EPS 025 Up Significant Ispire Technology ISPR Q1 2026 Earnings Miss by Significant Key Takeaways iQSTEL IQST Declines 077 Amid Market Weakness 20260515 Pitney Bowes PBI Q1 2026 Earnings Surprise EPS 047 Up Significant PMV Pharmaceuticals PMVP Q1 2026 Earnings Why the Beat Matters Floor FND Q1 2026 Results Miss Estimates EPS 037 vs 042 Europes Stablecoin Project Expands to 37 Lenders Signaling Growing Institutional Adoption Fintech Firm Mercury Achieves 52 Billion Valuation Defying Sector Headwinds Garmin GRMN Q1 2026 Earnings 208 EPS Surges Past 186 Estimates Mercury Valuation Surges to 52 Billion Reflecting Resilience in Fintech Sector Oura Ring Maker Targets Over 9 Billion Valuation in Planned US IPO Gold Prices Hold Steady as Market Weighs Fed Policy and Geopolitical Risks Retail Sector Adds 22000 Jobs in April Yet Consumer Sentiment Shows Caution CTMX Q1 2026 Earnings Narrower Loss Exceeds Expectations as Pipeline Advances O Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Environment Netcapital Inc NCPL Q1 2026 Earnings EPS Misses Estimates Amidst Challenging Operating Environment Nokia Q1 2026 Earnings EPS Beats Estimates by 2285 as Cost Discipline Drives Profitability CCAP Q1 2026 Earnings Slight EPS Miss Amidst Stable Portfolio Performance SEALSQ Corp LAES Rallies Past Key Support Challenges Resistance at 374 Eaton Corporation ETN Gains Momentum Technical and Fundamental Drivers Behind the Uptrend Weatherford International WFRD Holds Steady Near Support Amid Quiet Trading TPCS Q1 2026 Earnings Net Loss of 015 Per Share Amid Operational Adjustments KNSA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Product Growth OFS Capital Corp Q1 2026 Earnings Stunning EPS Beat Driven by Investment Gains SOMN Q1 2026 Earnings Earnings Beat Estimates Amid Stable Operations American Homes 4 Rent AMH Q1 2026 Earnings Large EPS Beat Highlights Operational Strength SLDE Q1 2026 Earnings Strong Earnings Beat Highlights Improving Underwriting Performance Arvinas Inc ARVN Q1 2026 Earnings Narrower Loss Beats Expectations as Clinical Pipeline Advances